药品:专业
阿根廷公司从事该行业的公司：药品:专业
下面的列表包含在同一行业，药品:专业下运营的阿根廷公司。该列表有助于跟踪他们的表现、损益表等。按任何必要的指标排序，它可以显示行业中最贵的股票，例如ASTRAZENECA PLC CEDEAR EACH REP 0.5 ADR USD0.25，或具有最佳价格动态的股票，例如ABBVIE INC CEDEAR EACH 10 REPR 1 COM，从而有助于设计任何重点策略。
商品代码 | 市值 | 价格 | 更改 % | 成交量 | 相对交易量 | P/E | 摊薄每股收益 净利率，TTM | 每股收益缓慢增长 TTM同比 | 股息收益率 % 净利率，TTM | 板块 | 分析师评级 |
|---|---|---|---|---|---|---|---|---|---|---|---|
 LLYDELI LILLY AND COMPANY CEDEAR EACH 56 REP 1 (USD)DR | 809.64 T ARS | 14.700 USD | 0.00% | 220 | 0.59 | 114.09 | 124.85 ARS | +178.70% | 0.31% | 健康科技 | — |
| LLYELI LILLY AND COMPANY CEDEAR EACH 56 REP 1 DR | 809.64 T ARS | 17,250.000 ARS | +0.29% | 4.31 K | 0.67 | 138.16 | 124.85 ARS | +564.33% | 0.31% | 健康科技 | — |
 JNJDJOHNSON & JOHNSON CEDEAR EACH 15 REP 1 ORD SHS(USD)DR | 385.19 T ARS | 10.250 USD | −1.44% | 1.06 K | 0.31 | 29.98 | 352.44 ARS | +130.17% | 1.64% | 健康科技 | — |
| JNJJOHNSON & JOHNSON CEDEAR EACH 15 REP 1 ORD SHS DR | 385.19 T ARS | 11,950.000 ARS | −1.24% | 8.62 K | 0.38 | 33.91 | 352.44 ARS | +193.52% | 1.64% | 健康科技 | — |
| DJNJ3JOHNSON & JOHNSON CEDEAR(REPR 6.95% BDS) DR | 385.19 T ARS | 1,270.000 ARS | 0.00% | 195 | 16.81 | — | — | — | — | 健康科技 | — |
 ABBVDABBVIE INC CEDEAR EA 10 REP 1 COM(USD)DR | 341.72 T ARS | 18.700 USD | +5.65% | 271 | 4.60 | 7.73 | 2,343.37 ARS | +18.73% | 1.60% | 健康科技 | — |
| ABBVABBVIE INC CEDEAR EACH 10 REPR 1 COM DR | 341.72 T ARS | 21,925.000 ARS | +5.92% | 3.82 K | 3.09 | 9.36 | 2,343.37 ARS | +183.01% | 1.60% | 健康科技 | — |
 MRKDMERCK & CO INC CEDEAR EAC 5 RE 1 (USD)DR | 262.86 T ARS | 20.000 USD | 0.00% | 47 | 0.49 | 21.94 | 883.37 ARS | +319.19% | 1.60% | 健康科技 | — |
| MRKMERCK & CO INC CEDEAR (5 REP 1 USD0.50) DR | 262.86 T ARS | 23,375.000 ARS | 0.00% | 4.17 K | 0.88 | 26.46 | 883.37 ARS | +899.22% | 1.60% | 健康科技 | — |
 AZNDASTRAZENECA PLC CEDEAR EA RE 0.5 ADR (USD)DR | 229.57 T ARS | 35.800 USD | +2.43% | 31 | 1.27 | 51.18 | 677.80 ARS | +64.44% | 1.37% | 健康科技 | — |
| AZNASTRAZENECA PLC CEDEAR EACH REP 0.5 ADR USD0.25 DR | 229.57 T ARS | 41,950.000 ARS | −0.24% | 246 | 0.40 | 61.89 | 677.80 ARS | +291.99% | 1.37% | 健康科技 | — |
 NVSNOVARTIS AG CEDEAR EACH 4 REP 1DR | 218.78 T ARS | 30,950.000 ARS | +1.14% | 235 | 1.01 | — | — | — | 3.45% | 健康科技 | — |
 PFEDPFIZER INC CEDEAR 4 REP 1 ORD USD0.05(USD)DR | 158.03 T ARS | 6.740 USD | −1.61% | 1.01 K | 0.78 | 27.83 | 234.71 ARS | +35.96% | 3.16% | 健康科技 | — |
| PFEPFIZER INC CEDEAR EACH 4 REP 1 ORD USD0.05 DR | 158.03 T ARS | 7,830.000 ARS | −0.89% | 12.45 K | 0.81 | 33.36 | 234.71 ARS | +224.10% | 3.16% | 健康科技 | — |
 BMYDBRISTOL-MYERS SQUIBB CO CEDEAR EACH 3 REP 1 USDDR | 125.72 T ARS | 20.150 USD | +0.75% | 5 | 0.70 | — | −1,078.84 ARS | −253.68% | 2.00% | 健康科技 | — |
| BMYBRISTOL-MYERS SQUIBB CO CEDEAR EACH 3 REP 1 DR | 125.72 T ARS | 23,075.000 ARS | −0.54% | 428 | 0.73 | — | −1,078.84 ARS | −466.33% | 2.00% | 健康科技 | — |
 GSKDGSK PLC CEDEAR EACH REPR 1/4 ADR (USD)DR | 74.83 T ARS | 8.900 USD | +0.34% | 19 | 0.23 | 28.01 | 307.84 ARS | −37.30% | 3.02% | 健康科技 | — |
| GSKGSK PLC CEDEAR EACH REPR 1/4 ADR DR | 74.83 T ARS | 10,450.000 ARS | +0.24% | 188 | 0.44 | 33.95 | 307.84 ARS | +49.45% | 3.02% | 健康科技 | — |
 BIIBDBIOGEN INC CEDEAR EAC 13 RE 1 COM(USD)DR | 22.05 T ARS | 11.000 USD | −5.17% | 3 | 0.20 | 15.32 | 695.64 ARS | +96.62% | 0.00% | 健康科技 | — |
| BIIBBIOGEN INC CEDEAR EACH 13 REP 1 COM USD0.0005 DR | 22.05 T ARS | 13,100.000 ARS | −1.69% | 645 | 1.16 | 18.83 | 695.64 ARS | +368.68% | 0.00% | 健康科技 | — |
 RICHLABORATORIOS RICHMOND SACIF | 133.24 B ARS | 1,650.000 ARS | −1.20% | 5.64 K | 0.55 | 17.14 | 96.29 ARS | — | 0.00% | 健康科技 | — |
 ROSEINSTITUTO ROSENBUCH SA DE BIOLOGIA | 4.9 B ARS | 115.000 ARS | 0.00% | 687 | 0.26 | 26.94 | 4.27 ARS | +64.50% | 0.00% | 健康科技 | — |